John Butler is the founder of Akebia Therapeutics. Akebia Therapeutics has raised $115M in total funding. Latest round: IPO. Based in Cambridge, USA.
John P. Butler is the President and CEO of Akebia Therapeutics, a development-stage biotechnology company focused on renal diseases, which he joined in 2013. He led the company's relocation to Cambridge, MA, and oversaw its initial public offering in March 2014, raising approximately $115 million.
Full founder directory · Investor directory · Company funding database · Fundraising library